Literature DB >> 16860760

Altered development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk and Rlk.

Christine Broussard1, Christine Fleischacker, Christine Fleischecker, Reiko Horai, Madeva Chetana, Ana M Venegas, Leslie L Sharp, Stephen M Hedrick, B J Fowlkes, Pamela L Schwartzberg.   

Abstract

Mutations affecting the Tec kinases Itk and Rlk decrease T cell receptor-induced Ca(2+) mobilization and Erk kinase activation and impair both positive and negative thymic selection. Itk(-/-) and Rlk(-/-)Itk(-/-) mice also have decreased CD4:8 T cell ratios, suggestive of altered CD4:8 lineage commitment. Nonetheless, we find that CD8 single-positive (SP) thymocytes and peripheral CD8(+) T cells in these mice do not resemble conventional CD8(+) T cells. Instead, these cells express memory markers, rapidly produce interferon-gamma, and can be selected on hematopoietically derived cells, similar to MHC class Ib-restricted "innate-type" lymphocytes. Itk deficiency also greatly increases the number of cells selected by MHC class Ib. Expression of a hypersensitive Erk2 mutant partially corrects the CD8(+) T cell phenotypes in Itk(-/-) mice, arguing that altered signaling permits development of this innate-type CD8(+) cell population. Our results suggest that Tec kinases differentially regulate development of conventional versus nonconventional lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16860760     DOI: 10.1016/j.immuni.2006.05.011

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  110 in total

1.  A unique role for ITK in survival of invariant NKT cells associated with the p53-dependent pathway in mice.

Authors:  Qian Qi; Weishan Huang; Yuting Bai; Gabriel Balmus; Robert S Weiss; Avery August
Journal:  J Immunol       Date:  2012-03-07       Impact factor: 5.422

Review 2.  Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells.

Authors:  Hye-Jung Kim; Harvey Cantor
Journal:  Semin Immunol       Date:  2011-12       Impact factor: 11.130

3.  The NF-κB1 transcription factor prevents the intrathymic development of CD8 T cells with memory properties.

Authors:  Raffi Gugasyan; Elisha Horat; Sarah A Kinkel; Fiona Ross; George Grigoriadis; Daniel Gray; Meredith O'Keeffe; Stuart P Berzins; Gabrielle T Belz; Raelene J Grumont; Ashish Banerjee; Andreas Strasser; Dale I Godfrey; Philip N Tsichlis; Steve Gerondakis
Journal:  EMBO J       Date:  2011-11-29       Impact factor: 11.598

Review 4.  Selection of self-reactive T cells in the thymus.

Authors:  Gretta L Stritesky; Stephen C Jameson; Kristin A Hogquist
Journal:  Annu Rev Immunol       Date:  2011-12-05       Impact factor: 28.527

Review 5.  Coordination of receptor signaling in multiple hematopoietic cell lineages by the adaptor protein SLP-76.

Authors:  Martha S Jordan; Gary A Koretzky
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-17       Impact factor: 10.005

Review 6.  T-cell signaling regulated by the Tec family kinase, Itk.

Authors:  Amy H Andreotti; Pamela L Schwartzberg; Raji E Joseph; Leslie J Berg
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-02       Impact factor: 10.005

Review 7.  SLAM receptors and SAP influence lymphocyte interactions, development and function.

Authors:  Pamela L Schwartzberg; Kristen L Mueller; Hai Qi; Jennifer L Cannons
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

Review 8.  The Tec kinases Itk and Rlk regulate conventional versus innate T-cell development.

Authors:  Amanda L Prince; Catherine C Yin; Megan E Enos; Martin Felices; Leslie J Berg
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 9.  Biochemical signaling pathways for memory T cell recall.

Authors:  Donna L Farber
Journal:  Semin Immunol       Date:  2009-04       Impact factor: 11.130

Review 10.  Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk.

Authors:  Julie A Readinger; Kristen L Mueller; Ana M Venegas; Reiko Horai; Pamela L Schwartzberg
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.